• Aucun résultat trouvé

antiretroviral treatment

Impact of antiretroviral treatment on height evolution of HIV infected children

Impact of antiretroviral treatment on height evolution of HIV infected children

... ART: Antiretroviral treatment; BIC: Bayesian information criterion; BSV: Between-subject variability; CDC: Centers for Disease Control and Prevention; HAZ: Height-for-age z-score; IQR: Interquartile range; ...

10

Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study.

Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study.

... INTRODUCTION Cardiovascular diseases and lung cancer are becoming competing causes of death in people living with HIV and AIDS on antiretroviral treatment [1, 2]. Recent evidence suggests that the ...

28

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium

... doi: 10.3389/fmicb.2019.00613 Edited by: Joris Hemelaar, University of Oxford, United Kingdom Reviewed by: Fernando Gonzalez-Candelas, University of Valencia, Spain Dimitrios Paraskevis, National and Kapodistrian ...

14

Health-related quality of life and patient/provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral
treatment

Health-related quality of life and patient/provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment

... Abstract The aim of this study was to investigate factors associated with better health-related quality of life (HRQL) during the first three years after starting PI-containing antiretroviral treatment. ...

15

Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals

Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals

... suppressive antiretroviral treatment (ART), increasing the risk of serious non- AIDS-related morbidity and mortality in treated patients ...anti-CMV treatment can reduce such activation ...

13

Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study

Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study

... active antiretroviral treatment (HAART; ...different antiretroviral drugs or any combination including one protease inhibitor, or one non-nucleoside reverse transcriptase inhibitor or one integrase ...

13

Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study

Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study

... of antiretroviral treatment (ART) are associated with metabolic complications, especially lipodystrophy, which has been well described among HIV-infected adults and children on ART in developed ...

10

Prevalence and determinants of HIV shedding in breast milk during continued breastfeeding among Zambian mothers not on antiretroviral treatment (ART)

Prevalence and determinants of HIV shedding in breast milk during continued breastfeeding among Zambian mothers not on antiretroviral treatment (ART)

... = antiretroviral treatment, ARV = antiretroviral, BMC = breast milk cell, CAV = cell-associated HIV, CD4 = cluster of differentiation 4, CFV = cell-free HIV, CI = confidence interval, DNA = ...

9

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo

... to antiretroviral treatment against HIV in resource‑limited ...highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub‑saharan Africa and ...

9

Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program

Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program

... 2. Adam BD, Maticka-Tyndale E, Cohen JJ. Adherence practices among people living with HIV. AIDS care. 2003; 15(2):263–74. Epub 2003/07/15. https://doi.org/10.1080/0954012031000068407 PMID: 12856347 . 3. Brennan AT, ...

11

Chronic kidney disease and HIV in the era of antiretroviral treatment : findings from a 10-year cohort study in a west African setting

Chronic kidney disease and HIV in the era of antiretroviral treatment : findings from a 10-year cohort study in a west African setting

... Abstract Background: It has been reported that people living with HIV in West Africa exhibited the highest risks for chronic kidney disease (CKD) in the world. Here, we aimed at determining the CKD frequency and changes ...

11

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

... Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Statistical methods Virologic response and relapse rates were analyzed using survival analysis methods for interval censored data (nonparametric maximum ...

11

Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon

Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon

... People living with HIV (PLHIV) constitute an espe- cially vulnerable population as they bear particularly large disease-related health expenses which may severely affect their household welfare [ 2 ]. Catastrophic health ...

8

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

... Found at doi:10.1371/journal.pmed.0040257.sd005 (386 KB PDF). Acknowledgments The authors thank Laurence Dequae-Merchadou for her help with statistical analyses. The authors also thank the Secretariat of the MTCT-Plus ...

13

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ...

34

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon

... HIV treatment facilities: Medical Unit (MU) Baptist Nkwen, MU Cameroon Baptist Church Mboppi Douala, MU St Luc Mbalmayo, MU Police Yaoundé, MU District Hospital Mbengwi, MU St Vincent Dschang, MU Baptist ...

9

en
                                                                    fr

en fr « universal » antiretroviral treatment in HIV-infected adults : Specificities of sub-saharian Africa Traitement antirétroviral « universel » chez l’adulte infecté par le VIH : Spécificités de l'Afrique sub-Saharienne

... Ceci s'est notamment illustré par les essais Cotrimo-CI ANRS 059 (prophylaxie précoce des infections opportunistes par le cotrimoxazole) et Temprano ANRS 12136 (traitement antirétrovir[r] ...

182

Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature

Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature

... and treatment in due time, the con- sensus today is that individuals should be diagnosed as early as possible in the course of HIV infection, that is to say, before eligibil- ity criteria for antiretroviral ...

12

Adherence to and effectiveness of Highly Active Antiretroviral Treatment for HIV infection: assessing the bidirectional relationship

Adherence to and effectiveness of Highly Active Antiretroviral Treatment for HIV infection: assessing the bidirectional relationship

... In specification (i) the variable (CD4 t - CD4t 0 ) is included as a plain covariate (i.e. not interacted with another covariate) in the adherence equation In specification (ii) the interaction terms between the variable ...

36

en
                                                                    fr

en fr Early antiretroviral treatment in HIV-1-infected infants Traitement précoce des nourrissons vivant avec le VIH-1

... 5. Les patients contrôleurs après arrêt d’un traitement instauré précocement (« post- treatment controllers » (PTC)) (Table 1) 5.1. Données chez les adultes traités en primo-infection Plusieurs études et cohortes ...

18

Show all 1884 documents...

Sujets connexes